EP0209971A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Polyether antibiotic and process for its production
Assignee: Eli Lilly and Co
•
Filing: 1986-05-27
•
Granted: —
•
Expires: 2006-05-27
Abstract
Abstract Antibiotic A80438 of formula: prepared by the submerged cultivation of Streptomyces species.
Inventors
- 👤 Robert L. Hamill
- 👤 Raymond Che-Fong Yao
- 👤 Walter Mitsuo Nakatsukasa
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 16:22
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/01; A; A23; A23K; A23K20/00; A23K20/10; A23K20/195; A23K50/00; A23K50/30; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12P; C12P17/00; C12P17/18; C12P17/181; C12P19/00; C12P19/44; C12P19/445; C12R; C12R2001/00; C12R2001/01; C12R2001/465
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
20 words
Antibiotic A80438 of the formula 1: or an acyl, alkyl ester, alkyl ether or urethane derivative, or a salt thereof.
Claim 2
Dependent Claim
20 words
Antibiotic A80438 of the formula 1: or an acyl, alkyl ester, alkyl ether or urethane derivative, or a salt thereof.
Claim 3
Dependent Claim
1 words
A80438.
Claim 4
Dependent Claim
1 words
A80438.
Claim 5
Dependent Claim
5 words
The sodium salt of A80438.
Claim 6
Dependent Claim
5 words
The sodium salt of A80438.
Claim 7
Dependent Claim
23 words
A compound of formula 1 as claimed in any one of claims 1 to 3, for use in preventing or treating microbial infections.
Claim 8
Dependent Claim
21 words
A compound of formula 1 as claimed in any one of claims 1 to 3, for use as a growth promotor.
Claim 9
Dependent Claim
71 words
A process for preparing a compound of formula 1, as claimed in any one of claims l to 3, which comprises cultivating Streptomyces bobili NRRL 15971, or Streptomyces pactum NRRL 15970, or an A80438-producing variant, mutant or recombinant thereof, in a culture medium containing assimilable sources of carbon, nitrogen, and inorganic salts under submerged aerobic fermentation conditions until antibiotic A80438 is produced, optionally followed by separating A80438 from the culture medium.
Claim 10
Dependent Claim
4 words
Streptomyces bobili NRRL 15971.
Claim 11
Dependent Claim
4 words
Streptomyces bobili NRRL 15971.
Claim 12
Dependent Claim
4 words
Streptomyces pactum NRRL 15970.
Claim 13
Dependent Claim
4 words
Streptomyces pactum NRRL 15970.
Claim 14
Dependent Claim
159 words
A poultry feedstuff composition comprising a first component which is a compound of formula 1 as claimed in any one of claims 1 to 3 and a second component which is selected from the group consisting of a) nicarbazin, b) 4,4'-dinitrocarbanilide, c) a naphthalenamine of the formula wherein: R 2 is C 1 -C 4 alkyl; R 3 is halogen, C 1 -C 4 fluoroalkyl, C 1 -C 4 fluoroalkoxy or C 1 -C 4 fluoroalkylthio; R 4 is halogen; R 5 is hydrogen or halogen; m is 0, 1 or 2; and n is 0 or 1; with the proviso that, when an R 4 substituent exists, it is at other than the 2-position; d) a benzenamine selected from 2,4-dinitro-N-[4-(trifluoromethoxy)phenyl]-6-(trifluoromethyl)benzenamine, 2,4-dinitro-N-[4-(1,1,2,2-tetrafluoroethoxy)-phenyl]-6-(trifluoromethyl)benzenamine or 2,4-dinitro-N-[4-(pentafluoroethoxy)phenyl]-6-(trifluoromethyl)-benzenamine; e) metichlorpindol; or f) a pharmaceutically acceptable salt of an (a)-(e) compound; the components being present in the feedstuff in amounts which, in combination, are synergistic as to at least one coccidiosis-causing strain of Eimeria.
Claim 15
Dependent Claim
76 words
A process for preparing antibiotic A80438 of the formula 1: or an acyl, alkyl ester, alkyl ether or urethane derivative, or a salt thereof, which comprises cultivating Streptomyces bobili NRRL 15971, or Streptomyces 2actum NRRL 15970, or an A80438-producing variant, mutant or recombinant thereof, in a culture medium containing assimilable sources of carbon, nitrogen, and inorganic salts under submerged aerobic fermentation conditions until antibiotic A80438 is produced, optionally followed by separating A80438 from the culture medium.
Claim 16
Dependent Claim
76 words
A process for preparing antibiotic A80438 of the formula 1: or an acyl, alkyl ester, alkyl ether or urethane derivative, or a salt thereof, which comprises cultivating Streptomyces bobili NRRL 15971, or Streptomyces 2actum NRRL 15970, or an A80438-producing variant, mutant or recombinant thereof, in a culture medium containing assimilable sources of carbon, nitrogen, and inorganic salts under submerged aerobic fermentation conditions until antibiotic A80438 is produced, optionally followed by separating A80438 from the culture medium.
Claim 17
Dependent Claim
13 words
A process according to claim 1 for preparing A80438 as its sodium salt.
References Cited (Backward Citations)
FR2322596A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.